NF-κB; the Critical Link between Immune and Metabolic Pathways: Could NF-κB be Used as a Novel Diagnostic and Prognostic Biomarker for Non-Alcoholic Steatohepatitis?
OBM Hepatology and Gastroenterology · 2019
DOI: 10.21926/obm.hg.1902020 ↗Kurz gefasst
Fachartikel in der Zeitschrift OBM Hepatology and Gastroenterology, 2019. Verfasst von Athina Chasapi und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
(1)
Background
A great number of inflammatory mediators and metabolic biomarkers have been shown to contribute to the development and progression of obesity-induced pathologies, including insulin resistance and nonalcoholic fatty liver disease (NAFLD). Many of those mediators are either targets or activators of nuclear factor-κappa B (NF-κB), which is a key transcription factor and plays a pivotal role in the homeostasis and the regulation of inflammatory signaling pathways in the liver. (2)
Methods
Our study population consisted of 50 morbidly obese patients undergoing planned bariatric surgery, during which biopsies were taken from visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), skeletal muscle (SM), extramyocellular adipose tissue (EMAT) and liver. We evaluated the differential protein expression of NF-κB, ERβ (Estrogen Receptor β), NFATc1 (Nuclear factor of activated T-cells) and PGC1a (peroxisome proliferator-activated receptor gamma coactivator 1-alpha) by immunohistochemistry. (3)
Results
We found that NF-κB is the key biomarker in a complicated intra- and intertissue co-expression network that interconnects metabolic and immune signaling pathways. We also demonstrated its role in lipid metabolism and possibly in the development of skeletal muscle insulin resistance and nonalcoholic steatohepatitis (NASH). (4)
Conclusions
Our findings suggest that NF-κB may be the critical link between immune and metabolic pathways and could represent a future preventive and therapeutic target against obesity-induced metabolic diseases. We hope that our study will contribute to the better understanding of the complex intertissue connections that are disrupted in obesity and its associated comorbidities.
Zitieren
APA
Chasapi, A., Balampanis, K., Tanoglidi, A., Kourea, E., Lambrou, G. I., Lambadiari, V., Kalfarentzos, F., Hatziagelaki, E., Melachrinou, M., & Sotiropoulou-Bonikou, G. (2019). NF-κB; the Critical Link between Immune and Metabolic Pathways: Could NF-κB be Used as a Novel Diagnostic and Prognostic Biomarker for Non-Alcoholic Steatohepatitis?. OBM Hepatology and Gastroenterology. https://doi.org/10.21926/obm.hg.1902020
Vancouver
Chasapi A, Balampanis K, Tanoglidi A, Kourea E, Lambrou GI, Lambadiari V, et al. NF-κB; the Critical Link between Immune and Metabolic Pathways: Could NF-κB be Used as a Novel Diagnostic and Prognostic Biomarker for Non-Alcoholic Steatohepatitis?. OBM Hepatology and Gastroenterology. 2019. doi:10.21926/obm.hg.1902020
BibTeX
@article{Chasapi2019,
author = {Chasapi, Athina and Balampanis, Konstantinos and Tanoglidi, Anna and Kourea, Eleni and Lambrou, George I. and Lambadiari, Vaia and Kalfarentzos, Fotios and Hatziagelaki, Erifili and Melachrinou, Maria and Sotiropoulou-Bonikou, Georgia},
title = {NF-κB; the Critical Link between Immune and Metabolic Pathways: Could NF-κB be Used as a Novel Diagnostic and Prognostic Biomarker for Non-Alcoholic Steatohepatitis?},
journal = {OBM Hepatology and Gastroenterology},
year = {2019},
doi = {10.21926/obm.hg.1902020}
}
EUVIMED